Biopol Chemicals IPO, a SME book-built issue, will raise fresh capital worth ₹31.26 Crore through 28,94,400 Equity Shares, face value at ₹10/share.
The Biopol Chemicals IPO starts its bidding from 6 February 2026 and ends on 10 February 2026. Biopol Chemicals to finalise its allotment on 11 February 2026 and list at NSE SME, which is planned on 13 February 2026.
Biopol Chemicals Limited fixes the IPO shares within a price band of ₹102/share – ₹108/share. The retail application must have a bid size of 2,400 shares, 1,200 shares/lot, which brings a minimum investment for retail investors to ₹2,59,200, based on the upper band. The minimum lot for HNI is 3 lots (3,600 shares), taking the minimum investment to ₹3,88,800.
Biopol Chemicals IPO: Details
| IPO Opens | 6 February 2026 |
| IPO Closes | 10 February 2026 |
| Face value | ₹10 |
| Price Band | ₹102 to ₹108/share |
| IPO Lot Size | 1,200 shares |
| Fresh issue | 28,94,400 Equity Shares (₹31.26 Crore) |
| Issue Type | Book-built |
| Listing | NSE SME |
| Total Issue Size (₹ Crore) | ₹31.26 Crore (28,94,400 Equity Shares) |
| Minimum Retail Investment | ₹2,59,200 |
Biopol Chemicals IPO Timeline
| Bid Opening Date | 6 February 2026 |
| Bid Closing Date | 10 February 2026 |
| Allotment | 11 February 2026 |
| Refunds Initiated | 12 February 2026 |
| Share Credit Date | 12 February 2026 |
| Listing Date | 13 February 2026 |
| UPI mandate Cut-off time | 10 February 2026 (5 PM) |
Biopol Chemicals Key Performance Indicators (KPIs)
| KPIs | 2025 | 2024 | 2023 |
| ROE (%) | 38.1 | 53.91 | 30.79 |
| ROCE (%) | 30.57 | 34.03 | 17.83 |
| Debt-Equity Ratio (in times) | 0.57 | 0.39 | 3.74 |
| RoNW (%) | 32 | 32.19 | 29.4 |
| PAT Margin (%) | 8.81 | 11.63 | 2.72 |
| EBITDA Margin (%) | 13.3 | 17.38 | 8.06 |
Biopol Chemicals Limited: Financial Information
| 2025 (in ₹ lakh) | 2024 (in ₹ lakh) | 2023 (in ₹ lakh) | |
| Revenue | 4,912.84 | 2,546.97 | 1,932.43 |
| Assets | 4,887.52 | 3,147.53 | 1,755.69 |
| Profit After Tax | 433.01 | 296.23 | 52.59 |
Subscription Status: Biopol Chemicals IPO
Biopol Chemicals IPO subscription rate. Check them here!
Subscription Details Not Yet Available
Subscription information will be displayed once the bidding process starts.
Bidding is open from 10:00 AM to 5:00 PM on public issue days.
Biopol Chemicals IPO GMP
Biopol Chemicals IPO’s last GMP as of 27 January comes at ₹0. The listing price expectation is ₹108, which is equal to the upper band, which keeps the expected gain at 0.00%.
| Date | GMP (₹) | Estimated Listing Price | Estimated Listing Gain |
| 27 January 2026 | ₹0 | ₹108 | ₹0 (0.00%) |
Note: The Grey Market Premium (GMP) is an unofficial indicator that fluctuates based on changing investor sentiment, subscription rates, and market conditions.
Biopol Chemical IPO Reservation
The Biopol Chemicals IPO includes 28,94,400 Equity Shares for allocation among market makers, QIBs, NIIs, and retail investors. Here’s how the shares are reserved!
| Category | % of Shares Offered | Shares offered |
| Market makers | 5.22% | 1,51,200 |
| QIBs | 23.71% | 6,86,400 |
| Retail Investors | 33.25% | 9,62,400 |
| NII shares offered (HNI) | 37.81% | 10,94,400 |
| Total Shares Offered | 100% | 28,94,400 |
Biopol Chemicals IPO Lot Size
The minimum bid size for retail investors is 2,400, which is 2 lots with 12,00 shares/lot.
| Application | Lot Size | Shares | Amount(in ₹) |
| Retail Investors Minimum Application | 2 | 2,400 | ₹2,59,200 |
| Retail Investors Maximum Application | 2 | 2,400 | ₹2,59,200 |
| S-HNI Minimum Application | 3 | 3,600 | ₹3,88,800 |
| S-HNI Maximum Application | 7 | 8,400 | ₹9,07,200 |
| B-HNI Minimum Application | 8 | 9,600 | ₹10,36,800 |
Biopol Chemicals IPO: Anchor Investors Details
Biopol Chemicals IPO does not include any allocation to anchor investors.
The company has not allotted shares to anchor investors prior to the public issue, and the entire offer is available for subscription as per the IPO structure disclosed in the offer documents.
Biopol Chemicals IPO Prospectus
About Biopol Chemicals Limited
Biopol Chemicals Limited was founded on 12 April 2023, and is under the guidance of Chairman and Managing Director, Mr Santanu Sarkar.
The company operates in the speciality chemicals space, with activities spanning trading, manufacturing, and distribution. Its product portfolio covers categories such as silicones, emulsifiers, biochemicals, and polyelectrolytes, serving diverse industrial applications.
| Book Running Lead Managers (BRLM) | Smart Horizon Capital Advisors Private Limited |
| IPO Registrar | Bigshare Services Private Limited |
Objectives of Biopol Chemicals
| Particulars | Amount (in ₹ lakh) |
| Industrial land acquisition | 1,226.47 |
| Payment of borrowings | 1,110.00 |
Strengths Of Biopol Chemicals
- The order book: The company confirmed orders worth ₹1,330.85 lakh, as of January 2026, reflecting demand across products, and domestic and international markets.
- The manufacturing unit: The company owns a fully equipped facility in West Bengal with 18.25 lakh litres annual capacity, which supports efficient, quality-driven speciality chemical production.
- Quality standards & compliance: The company’s ISO-certified operations and ZDHC Level 3 accreditation across 42 products highlight strict quality control and regulatory compliance.
- Presence in Gujarat and West Bengal: The company’s strong revenue concentration, operational infrastructure, and expansion plans in Gujarat and West Bengal strengthen scale, logistics, and market reach.
Risks of Biopol Chemicals
- Industry concentration risk: The company depends highly on the textile sector, which subjects it to demand swings, policy changes, and industry downturns.
- Geographic revenue concentration: The company generates a significant share of revenues from West Bengal, Gujarat, and Bangladesh, and any regional disruptions can impact operations.
- Supplier dependency risk: The company’s dependence on a limited supplier base for critical raw materials subjects it to supply interruptions and input cost pressures.
- Expansion & execution risk: The company’s proposed expansion in Gujarat involves regulatory, operational, and execution risks that may affect growth timelines and financial outcomes.
Biopol Chemicals IPO Review
Biopol Chemicals IPO comes from a young but fast-scaling speciality chemicals player with rising revenues and improving profitability. The company’s strong ROE, a confirmed order book, and certified manufacturing add comfort.
However, heavy textile dependence and regional concentration make this issue better suited for risk-aware SME investors.
Other Recent IPO List
List stating currently open and upcoming IPOs in India 2026!
| KRM Ayurveda IPO | Kasturi Metal Composite IPO |
| Hannah Joseph Hospital IPO | Digilogic Systems IPO |
| Accretion Nutraveda IPO | Shayona Engineering IPO |
| NFP Sampoorna Foods IPO | Shadowfax Technologies IPO |
Biopol Chemicals IPO FAQs
The Biopol Chemicals IPO is an SME book-built issue aiming to raise ₹31.26 crore through a fresh issue of 28,94,400 equity shares. The proceeds will support land acquisition and balance sheet strengthening for future growth.
Investors can apply for the Biopol Chemicals IPO through ASBA via net banking or UPI-enabled IPO platforms offered by brokers. Retail investors must bid for at least 2,400 shares within the specified price band during the subscription window.
The Biopol Chemicals IPO shows strength through strong financial ratios and a growing order book. However, industry concentration and regional revenue dependence add risk. It suits investors who are comfortable with SME volatility and medium-term business execution risks.
The Biopol Chemicals IPO, with GMP currently at ₹0, keeps the listing gains appearing limited. The returns will depend on post-listing earnings growth, order execution, and margin stability rather than short-term price momentum.
The Biopol Chemicals IPO opens for subscription on 6 February 2026 and closes on 10 February 2026, with bids accepted during market hours on all working days.
The retail lot size for the Biopol Chemicals IPO is 1,200 shares per lot, with a minimum application of two lots, totalling 2,400 shares and an investment of ₹2,59,200 at the upper price band.
The Biopol Chemicals IPO allotment is scheduled to be finalised on 11 February 2026, following the closure of the bidding process.
The Biopol Chemicals IPO is expected to list on the NSE SME platform on 13 February 2026, subject to final approvals and completion of post-issue formalities.
